Société des Industries Pharmaceutiques de Tunisie - S.A. Share Price
Equities
SIPHA
TN0006670012
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 TND | +4.53% | -.--% | +4.26% |
Sales 2021 * | 9.51M 3.04M 253M | Sales 2022 * | - | Capitalization | 7.06M 2.25M 188M |
---|---|---|---|---|---|
Net income 2021 * | -22M -7.03M -586M | Net income 2022 * | - | EV / Sales 2021 * | 7.11 x |
Net Debt 2021 * | 60.6M 19.36M 1.61B | Net cash position 2022 * | - 0 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.32
x | P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 20.01% |
1 day | +4.53% | ||
1 month | +4.53% | ||
3 months | +4.53% | ||
6 months | -38.75% | ||
Current year | +4.26% |
Managers | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 19/17/19 |
Emin Cherni
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 19/17/19 |
Wasila Hamami
BRD | Director/Board Member | - | 01/19/01 |
Ridha Saidi
BRD | Director/Board Member | - | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
+4.26% | 2.25M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- SIPHA Stock